 |
Alarçon T, Domingo D, Lopez-Brea M.
Antibiotic resistance problems with Helicobacter pylori.
Int J Antimicrob Agents 1999; 12: 19-26
|
|
|
Aoyama N, Shinoda Y, Matsushima Y, Shirasaka D, Kinoshita Y, Kasuga M, Chiba T.
Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDs or stress?
J Gastroenterol 2000; 35 (S1): 33-37
|
|
|
Archimandritis A, Balatsos V, Delis V, Manika Z, Skandalis N.
"Reappearance" of Helicobacter pylori after eradication: implications on duodenal ulcer recurrence: a prospective 6 year study.
J Clin Gastroenterol 1999; 28: 345-347
|
|
|
Auroux J, Lamarque D, Tankovic J, Benamouzig R, Mahé S, Chaumette MT, Delchier JC.
Comparaison de la quantification de l'infection gastrique à Helicobacter pylori par culture, histologie, et test respiratoire à l'urée marquée au 13C.
Gastroenterol Clin Biol 1998; 22: 407-412
|
|
|
Balint GA.
On a possible interrelationship among smoking, gastric ulceration and endogenous prostacyclin.
Exp Toxicol Pathol 2002; 54: 39-41
|
|
|
Barchielli A, Amorosi A, Balzi D, Crocetti E, Nesi G.
Long-term prognosis of gastric cancer in a European country: a population-based study in Florence (Italy).
10-year survival of cases diagnosed in 1985-1987.
Eur J Cancer 2001; 37: 1674-1680
|
|
|
Bobrzynski A, Beben P, Budzynski A, Bielanski W, Plonka M, Konturek S.
Incidence of complications of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication.
Med Sci Monit 2002; 8: 554-557
|
|
|
Brandimarte G, Tursi A, di Cesare L, Gasbarrini G.
Antimicrobial treatment for peptic stenosis: a prospective study.
Eur J Gastroenterol Hepatol 1999; 11: 731-734
|
|
|
Brock J, Sauaia A, Ahnen D, Marine W, Schluter W, Stevens BR, Scinto JD, Karp H, Bratzler D.
Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease.
Results from a quality improvement project. JAMA 2001; 286: 1985-1993
|
|
|
Brzozowski T, Konturek SJ, Majka J, Dembinski A, Drozdowicz D.
Epidermal growth factor, polyamines, and prostaglandins in healing of stress-induced gastric lesions in rats.
Dig Dis Sci 1993; 38: 276-283
|
|
|
Bytzer P, Stubbe Teglbjaerg P and the Danish Ulcer Study Group.
Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics and prognosis-results from a randomized trial with 2-year follow-up.
Am J Gastroenterol 2001; 96: 1409-1416
|
|
|
Calam J, Baron JH.
Pathophysiology of duodenal and gastric ulcer and gastric cancer.
BMJ 2001; 323: 980-982
|
|
|
Calam J.
The somatostatin-gastrin link of Helicobacter pylori infection.
Ann Med 1995; 27: 569-573
|
|
|
Canoy DS, Hart AR, Todd CJ.
Epidemiology of duodenal ulcer perforation: a study on hospital admission in Norfolk, United Kingdom.
Dig Liv Dis 2002; 34: 322-327
|
|
|
Censini S, Stein M, Covacci A.
Cellular responses induced after contact with Helicobacter pylori.
Curr Opin Microbiol 2001; 4: 41-46
|
|
|
Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VKS, Wu JCY, Lau JYW, Hui WK, Lai MS, Chan HLY, Sung JJY.
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
N Engl J Med 2001; 344: 967-973
|
|
|
Chan FK, Sung JJ, Lee YT, Leung WK, Chan LY, Yung MY, Chung SC.
Does smoking predipose to peptic ulcer relapse after eradication of Helicobacter pylori?
Am J Gastroenterol 1997; 92: 442-445
|
|
|
Chen TS, Chang FY, Lee SD.
Smoking and male gender rather than CagA protein are associated with increased risk for duodenal ulcer in Helicobacter pylori-infected patients in Taiwan.
Dig Dis Sci 1999; 44: 2076-2080
|
|
|
Choi J, Yoon SH, Kim JE, Rhee KH, Youn HS, Chung MH.
Gene-specific oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa.
Int J Cancer 2002; 99: 485-490
|
|
|
Chowdhary SK, Bhasin DK, Panigrahi D, Malik AK, Kataria RN, Behra A, Roy P, Singh K.
Helicobacter pylori infection in patients with perforated duodenal ulcer.
Trop Gastroenterol 1998; 19: 19-21
|
|
|
Ciok J, Dzieniszewski J, Lucer C.
Helicobacter pylori eradication and antral intestinal metaplasia-two years follow-up study.
J Physiol Pharmacol 1997; 48 (S4): 115-122
|
|
|
Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Hawkey C, Atherton JC.
High prevalence of potentially virulent strains of Helicobacter pylori in the general male British population.
Gut 2000; 47: 23-25
|
|
|
Danish Dyspepsia Study Group.
Value of the unaided clinical diagnosis in dyspeptic patients in primary care.
Am J Gastroenterol 2001; 96: 1417-1421
|
|
|
Debongnie J-C, Donnay M, Mairesse J, Lamy V, Dekoninck X, Ramdani B.
Gastric ulcers and Helicobacter heilmannii.
Eur J Gastroenterol Hepatol 1998; 10: 251-254
|
|
|
Debongnie J-C, Wibin E, Timmermans M, Mairesse J, Dekoninck X.
Are perforated gastroduodenal ulcers related to Helicobacter pylori?
Acta Gastroenterol Belgica 1995; LVIII: 208-212
Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.
BMJ 2002; 325: 619
|
|
|
Di Mario F, Grasso GA, Battaglia G, De Boni M, Vianello F, De Bona M, Pasquino M, Chiozzini G, Saggioro A.
Valutazione dei costi della terapia di mantenimento (sei mesi) con ranitidina 150 mg vs omeprazolo 20 mg vs omeprazolo 20 mg a giorni alterni nell'ulcera duodenale.
Minerva Gastroenterol Dietol 1993; 39: 83-87
|
|
|
Di Mario F, Battaglia G, Saggioro A, Chiozzini P, D'Angelo A, Marin R, Morelli A, Vezzadini P, Buscarini L, Cavassini G, Naccarato R. A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer.
A randomized, double blind, multicentre, 2-year study.
Ital J Gastroenterol 1991; 23: 253-256
|
|
|
D'Incà R, Sturniolo G, Cassaro M, Di Pace C, Longo G, Callegari I, Rugge M.
Prevalence of upper gastrointestinal lesions and Helicobacter pylori infection in Crohn's disease.
Dig Dis Sci 1998; 43: 988-992
|
|
|
Dobrilla G. Patologia gastrointestinale da FANS.
Dati recenti in tema di patogenesi e di prevenzione.
Recenti Progr Med 1999; 90: 109-116
|
|
|
Dobrilla G, Zancanella L, Amplatz S.
The need for long-term treatment of peptic ulcer.
Aliment Pharmacol ther 1993; 7 (S2): 3-15
|
|
|
Ecclissato C, Carvalho AFN, Ferraz JGP, de Nucci G, De Souza CAF, Pedrazzoli jr J.
Prevalence of peptic lesions in asymptomatic healthy volunteers.
Dig Liv Dis 2001; 33: 403-406
|
|
|
Elizalde JI, Gomez J, Panes J, Lozano M, Casadevall M, Ramirez J, Pizcueta P, Marco F, Diaz de Rojas F, Granger DN, Piqué JM.
Platelet activation in mice and human Helicobacter pylori infection.
J Clin Invest 1997; 100: 996-1005
|
|
|
El-Zimaity HM, Ramchatesingh J, Saeed MA, Graham DY.
Gastric intestinal metaplasia: subtypes and natural history.
J Clin Pathol 2001; 54: 679-683
|
|
|
El-Zimaity HM, Graham DY.
Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System.
Hum Pathol 1999; 30: 72-77
|
|
|
Feldman M. Gastric secretion. In: Sleisenger & Fordtran's.
Gastrointestinal and Liver Disease.
Saunders Ed. Philadelphia USA pagg 715-731
|
|
|
Folkman J, Szabo S, Stovroff M, McNeil P, Shing Y. Duodenal ulcer.
Discovery of a new mechanism and development of angiogenic therapy that accelerates healing.
Ann Surg 1991; 214: 414-425
|
|
|
Futami H, Takashima M, Furuta T, Hanai H, Kaneko E.
Relationship between Helicobacter pylori infection and gastric metaplasia in the duodenal bulb in the pathogenesis of duodenal ulcer.
J Gastroenterol Hepatol 1999; 14: 114-119
|
|
|
Gisbert JP, Gonzalez L, Calvet X, Roqué M, Gabriel R, Pajares JM.
Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
Aliment Pharmacol Ther 2001; 15: 917-926
|
|
|
Goldstein JL Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis?
Eur J Gastroenterol Hepatol 2000; 12 (S1): 11-15
|
|
|
Halter F, Tarnawski AS, Schmassmann A, Peskar BM.
Cyclooxygenase 2 implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives.
Gut 2001; 49: 443-453
|
|
|
Hansen PS, Petersen SB, Varning K, Mielsen H.
Additive effects of Helicobacter pylori lipopolysaccharide and proteins in monocyte inflammatory responses.
Scand J Gastroenterol 2002; 37.765-771
|
|
|
Hawkey CJ, Naesdal J, Wilson I, Langstrom G, Swannell AJ, Peacock RA, Yeomans ND.
Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
Gut 2002a; 51: 336-343
|
|
|
Hawkey CJ, Wilson I, Naesdal J, Langstrom G, Swannell AJ, Yeomans ND.
Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
Gut 2002b; 51: 344-350
|
|
|
Hayashi S, Sugiyama T, Amano KI, Isogai H, Isogai E, Aihara M, Kikuchi M, Asaka M, Yokota K, Oguma K, Kujii N, Hirai Y.
Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
Antimicrob Agents Chemother 1998; 42: 1895-1899
|
|
|
Hermansson M, Stael Von Holstein C, Zilling T.
Peptic ulcer perforation before and after the introduction of H2-receptor blockers and proton pump inhibitors.
Scand J Gastroenterol 1997; 32: 523-529
|
|
|
Higham J, Kang JY, Majeed A.
Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects.
Gut 2002; 50: 460-464
|
|
|
Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review.
Gastroenterology 1996; 110 :1244-1252
|
|
|
Imhof M, Ohman C, Hartwig A, Thon KP, Hengels KJ, Röher HD & Düsuk Study Group. Which peptic ulcers bleed? Results of a case-control study. Scand J Gastroenterol 1997; 32: 131-138
|
|
|
Interdisciplinary Group for Ulcer Study (GISU). Nizatidine 150 mg at night in the prophylaxis of gastric ulcer relapse: a 12-month prospective, randomized, double-blind multicentre study versus placebo. Eur J Gastroenterol Hepatol 1993; 5: 97-102
|
|
|
Ishibashi S, Iwakiri R, Shimoda R, Ootani H, Kawasaki S, Tadano J, Kikkawa A, Ootani A, Oda K, Fujise T, Yoshida T, Tsunada S, Sakata H, Fujimoto K. Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori. Helicobacter 2002; 7: 245-249
|
|
|
Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar CH. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995; 41: 5-7
|
|
|
Jones MK, Kawanaka H, Baatar D, Szabo IL, Tsugawa K, Pai R, Koh GY, Kim I, Sarfeh J, Tarnawski AS. Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEFG and Angiopoietin-1. Gastroenterology 2001; 121: 1040-1047
|
|
|
Kato M, Asaka M, Saito M, Sekine H, Ohara S, Toyota T, Akamatsu T, Nishizawa O, Kumagai T, Katsuyama T, Abe M, Kosaka M, Hariya M, Sawamura M, Tachikawa T. Clinical usefulness of urine-based enzyme-linked immunosorbent assay detection of antibody to Helicobacter pylori: a collaborative study among institutions in Japan. Helicobacter 2000; 5: 109-119
|
|
|
Kawai K, Shirakawa K, Misaki F, Hayashi K, Watanabe Y. Natural history and epidemiologic studies of peptic ulcer disease in Japan. Gastroenterology 1989; 96: 581-585
|
|
|
Keates S, Hitti YS, Upton M, Kelly C. Helicobacter pylori infection activates NF-kB in gastric epithelial cells. Gastroenterology 1997; 113; 1099-1109
|
|
|
Klotz U. Pharmacokinetic considerations in the eradication of Helicobacter pylori. Clin Pharmacokinet 2000; 38: 243-270
|
|
|
Konturek PC, Ernst H, Konturek SJ, Bobrzynski AJ, Faller G, Klingler C, Hahn EG. Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori. Gut 1997; 40: 463-469
|
|
|
Konturek PK, Brzozowski T, Konturek SJ, Dembinski A. Role of epidermal growth factor, prostaglandin and sulfhydryls in stress-induced gastric lesions. Gastroenterology 1990; 99: 1607-1615
|
|
|
Kuyvenhoven JP, Veenendaal RA, Vandenbroucke JP. Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the AB0 blood group system. Scand J Gastroenterol 1999; 34: 1082-1086
|
|
|
Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997; 24: 2-17
|
|
|
Labenz J, Blum AL, Bolten WW, Dragosics B, Rösch W, Stolte M, Koelz HR. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. Gut 2002; 51: 329-335
|
|
|
Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998; 93: 1409-15
|
|
|
Lanza and the Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. A guideline for the treatment and prevention of NSAID-induced ulcers. Am J Gastroenterol 1998; 93: 2037-2046
|
|
|
Levenstein S. The very model of a modern etiology: a biopsychosocial view of peptic ulcer. Psychosom Med 2000; 62: 176-185
|
|
|
Luman W, Zhao Y, Ng HS, Ling KL. Helicobacter pylori infection is unlikely to be transmitted between partners: evidence from genotypic study in partners of infected patients . Eur J Gastroenterol Hepatol 2002; 14: 521-528
|
|
|
Malfertheiner P, Mégraud F, O'Morain C, Hungin APS, Jones R, Axon A, Graham DY, Tytgat G & The European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection -The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180
|
|
|
Mamdani M, Rochon PA, Juurlink DN, Kopp A, Anderson GM, Naglie G, Austin PC, Laupacis A. Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs. BMJ 2002; 325: 624
|
|
|
Marais A, Mendz GL, Hazell SL, Mégraud F. Metabolism and genetics of Helicobacter pylori: the genome era. Microbiol Mol Biol Rev 1999, 63: 642-674
|
|
|
McColl KEL, Murray LS, Gillen D, Walker A, Wirz A, Fletcher J, Mowat C, Henry E, Kelman A, Dickson A. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H.pylori testing alone in the management of dyspepsia. BMJ 2002; 324: 999-
|
|
|
McColl K, El-Nujumi AM, Chittajallu Rs, Dahill SW, Dorrian CA, El-Omar E, Penman I, Fitzsimons EJ, Drain J, Graham H, Ardill JES, Bessent R. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993; 34:762-768
|
|
|
Mitchell HM, Hu P, Chi Y, Chen MH, Li YY, Hazell SL A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 1998; 114: 256-261
|
|
|
Nardone G, Staibano S, Rocco A, Mezza E, D'Armiento FP, Insabato L, Coppola A, Salvatore G, Lucariello A, Figura N, De Rosa G, Budillon G. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999; 44: 789-799.
|
|
|
Neri M. Diagnosi e trattamento dell'ulcera peptica in Italia: 1997-1999. IMS Health 2000
|
|
|
Ofman J, Wallace J, Badamgarav E, Chiou CF, Henning J, Laine L. The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage. Am J Gastroenterol 2002; 97: 1941-1950
|
|
|
Orsini B, Ciancio G, Surrenti E, Macrì G, Biagini MR, Milani S, Surrenti C. Serologic detection of CagA positive Helicobacter pylori infection in a Northern Italian population: its association with peptic ulcer disease. Helicobacter 1998; 3: 15-20
|
|
|
Ottenjann R, Hochter W. Notwendige diagnostik des peptiscehn ulcus. In: Blum AL. Ulus therapie. Springer, Berlin-Heidelberg-New York 1982.
|
|
|
Palmas F, Andriulli A, Canepa G, Gardino L, Boero M, Rocca G, Verme G. Monthly fluctuations of active duodenal ulcers. Dig Dis Sci 1984; 29: 983-987
|
|
|
Pellicano R. Ulcera da FANS. Gastroenterology Insight 2001; 1: 7-15
|
|
|
Pellicano R, Vanni E, Palmas F, Astegiano M, Leone N, Fagoonee S, Ponzetto A, Rizzetto M. Diagnosis of Helicobacter pylori infection: validation of a commercial non invasive salivary test against urea breath test and serology. Minerva Gastroenterol Dietol 2001; 47 : 111-116
|
|
|
Rege RV, Jones DB. Current role of surgery in peptic ulcer disease. In: Sleisenger & Fordtran's. Gastrointestinal and Liver Disease. Saunders Ed. Philadelphia USA pagg 797-809
|
|
|
Rugge M, Busatto G, Cassaro M, Shiao YH, Russo V, Leandro G, Avellini C, Fabiano A, Sidoni A, Covacci A. Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer 1999; 85: 2506-2511
Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM, Geis GS. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123: 241-249
|
|
|
Singh G, Triadafilopoulos G. Epidemiologia delle complicanze gastrointestinali indotte da FANS. J Rheumatol 1999; 56: 18-24
|
|
|
Slomiany BL, Slomiany A. Disruption in gastric mucin synthesis by Helicobacter pylori lipopolysaccharide involves ERK and p38 mitogen-activated protein kinase participation. Biochem Biophys Res Commun 2002; 294: 220-224
|
|
|
Sontag SJ, O'Connell S, Schnell T, Chejfec G, Seidel J, Sonnenber A. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin. Am J Gastroenterol 2001; 96: 1390-1395
|
|
|
Sonnenberg A, Pauly MP, Levenson SD, Schwartz JS. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer. Am J Manag Care 1999; 5: 53-59
|
|
|
Sonnenberg A, Everhart JE. The prevalence of self-reported peptic ulcer in the United States. Am J Public Health 1996; 86: 200-205
|
|
|
Spechler SJ. Peptic ulcer disease and its complications. In: Sleisenger & Fordtran's. Gastrointestinal and Liver Disease. Saunders Ed. Philadelphia USA pagg 747-781
|
|
|
Stevenson TH, Castillo A, Lucia LM, Acuff GR. Growth of Helicobacter pylori in various liquid and plating media. Lett Appl Microbiol 2000; 30: 192-196
|
|
|
Suzuki H, Miura S, Suzuki M, Terada S, Nakamura M, Tsuchiya M. Gastric mucosal injury: microcirculation and Helicobacter pylori. Keio J Med 1994; 43: 1-8
|
|
|
Svanes C, Søreide JA, Skarstein A, Fevang BT, Bakke P, Vollset SE, Svanes K, Søreide O. Smoking and ulcer perforation. Gut 1997; 41: 177-180
|
|
|
Tham TCK, Chen L, Dennison N, Johnston CF, Collins JSA, Ardill JES, Buchanan KD. Effect of Helicobacter pylori eradication on antral somato-statin cell density in humans. Eur J Gastroenterol Hepatol 1998; 10: 289-291
|
|
|
The Eurohepygast Study Group. Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast Study. Gut 2002; 50: 779-785
|
|
|
Toljamo KT, Niemela SE, Karttunen TJ, Karttunen RA, Karvonen AL, Piiparinen H, Lehtola JK. The role of Herpes simplex and Helicobacter pylori infection in the etiology of persistent or recurrent gastric erosions. A follow-up study. Dig Dis Sci 2002; 47: 818-822
|
|
|
Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzgerald LM, Lee N, Adams MD, Venter JC. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997; 388: 539-547
|
|
|
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. NEJM 2001; 345: 784-789
|
|
|
Vaira D, Malfertheiner P, Mégraud F, Axon A, Deltenre M, Gasbarrini G, O'Morain C, Pajares Garcia JM, Quina M, Tytgat GN, and The European Helicobacter pylori HpSA Study Group. Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicentre study. Am J Gastroenterol 2000; 95: 925-929
|
|
|
Zhang ZW, Patchett SE, Perrett D, Katelaris PH, Domizio P, Farthing MJG. The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut 1998; 43: 322-326
|
|
|
Wallace MB, Durkalski VL, Vaughan J, Palesch YY, Libby ED, Jowell PS, Nickl NJ, Schultz SM, Leung JW, Cotton PB. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut 2001, 49: 29-34
|
|
|
Willoughby DA, Moore AR, Colville-Nash PR. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet 2000; 355: ------
|
|
|
Wu MS, Hung HW, Wang JT, Tseng CC, Shun CT, Wang HP, Lee WJ, Lin JT. Helicobacter pylori-seronegative gastric carcinoma: a subset of gastric carcinoma with distinct clinicopathologic features. Hepatogastroenterology 1998; 45: 2432-2436
|
|
|
Wu MS, Shun CT, Lee WC, Chen CJ, Wang HP, Lee WJ, Lin JT. Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia. Br J Cancer 1998; 78: 125-128
|
|
|
Yamagata H, Kiyohara Y, Aoyagy K, Kato I, Iwamoto H, Nakayama K, Shimizu H, Tanizaki Y, Arima H, Shinohara N, Kondo H, Matsumoto T, Fujishima M. Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population. Arch Intern Med 2000; 160: 1962-1968
|
|
